Photo from wikipedia
1 Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy, 2 Laboratory of Methodology for Clinical Research, Department of Oncology,… Click to show full abstract
1 Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy, 2 Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy, Medica Scientia Innovation Research (MedSIR), New Jersey, United States, Medica Scientia Innovation Research (MedSIR), Barcelona, Spain, 5 IOB Institute of Oncology, Quiron Group, Madrid, Spain, 6 IOB Institute of Oncology, Quiron Group, Barcelona, Spain, 7 Vall d’Hebron Insititute of Oncology (VHIO), Barcelona, Spain, Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Journal Title: Frontiers in Oncology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!